Does MYCOPHENOLATE MOFETIL Cause Polyomavirus-associated nephropathy? 1,112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,112 reports of Polyomavirus-associated nephropathy have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 1.5% of all adverse event reports for MYCOPHENOLATE MOFETIL.
1,112
Reports of Polyomavirus-associated nephropathy with MYCOPHENOLATE MOFETIL
1.5%
of all MYCOPHENOLATE MOFETIL reports
91
Deaths
312
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From MYCOPHENOLATE MOFETIL?
Of the 1,112 reports, 91 (8.2%) resulted in death, 312 (28.1%) required hospitalization, and 74 (6.7%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 1,112 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
SIROLIMUS (161)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE